ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Codiak BioSciences Inc

Codiak BioSciences Inc (CDAK)

0.057
0.00
( 0.00% )
Updated: 20:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.057
Bid
0.0447
Ask
0.0448
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.057
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CDAK Latest News

Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process

CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics...

Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics...

Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting

– exoASO-STAT6 demonstrated durable pharmacokinetic/pharmacodynamic profile in preclinical models; biomarkers with clinical translational potential identified, providing a rationale for selecting...

Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress

– Patient enrollment continuing in Phase 1 clinical trial of exoASO™-STAT6 in patients with advanced hepatocellular carcinoma; preliminary data anticipated during 1H 2023 – – Presented preclinical...

Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses

– Data support advancement of Codiak’s engineered exosome bivalent vaccine candidate toward IND-enabling studies – CAMBRIDGE, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc...

Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages

– Data to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting – CAMBRIDGE, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a...

Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...

Codiak Announces Proposed Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...

Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring

– Enrollment continues in Phase 1 clinical trial of IV-administered exoASO™-STAT6 in patients with advanced hepatocellular carcinoma –                   – Prioritizing vaccine program funded by...

Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational Progress

– Reported platform-validating initial data from Phase 1 studies of exoSTING™ and exoIL-12™; plans to initiate Phase 2 studies for both programs in 1H 2023 – – Initiated patient dosing in Phase 1...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RZLVRezolve AI Ltd
$ 7.64
(55.28%)
1.76M
INVZWInnoviz Technologies Ltd
$ 0.18
(45.69%)
11.02k
OCTOEightco Holdings Inc
$ 3.59
(44.18%)
95.42M
ATGLAlpha Technology Group Limited
$ 2.03
(40.71%)
2.61M
CAPRCapricor Therapeutics Inc
$ 12.045
(32.36%)
30.4M
VTNRVertex Energy Inc
$ 0.1679
(-53.49%)
40.54M
CMCTCreative Media and Community Trust Corporation
$ 0.751
(-52.01%)
2.74M
SFIXStitch Fix Inc
$ 2.3101
(-38.40%)
16.26M
SHOTWSafety Shot Inc
$ 0.22
(-31.25%)
11.2k
BNZIBanzai International Inc
$ 5.772
(-29.95%)
2.5M
NVDANVIDIA Corporation
$ 123.04
(1.80%)
213.34M
CEROCERo Therapeutics Holdings Inc
$ 0.1062
(13.34%)
114.17M
MLGOMicroAlgo Inc
$ 0.256612
(18.69%)
109.53M
SQQQProShares UltraPro Short QQQ
$ 7.485
(-2.16%)
96.99M
OCTOEightco Holdings Inc
$ 3.5801
(43.78%)
95.42M

Discussion

View Full Feed
HokieHead HokieHead 4 minutes ago
Adding, thanks much!
BNCM
cityimport cityimport 5 minutes ago
LET'S CLEAR THE REMAINING OF 0.0006 ... ;)

SHARE HOLDINGS: 54,206,718 STRONG SHARES

ASII
ASII
Doc logic Doc logic 5 minutes ago
sukus,

The change was explained in one of the links dstock shared before but I don’t remember which one. The original version had lots of mostly non contributory chain lengths while chain lengths within a certain range proved to be very effective on at least two levels with regard to
NWBO
Jaxxm Jaxxm 5 minutes ago
I like those 5sss
ASII
GolfnutBoston GolfnutBoston 5 minutes ago
It’s more depressing to me that when I first started with this ticker $2k could buy 25,000 shares and now $2k can buy a million shares.
AFFU
Monksdream Monksdream 5 minutes ago
KSCP 10 day hourly
https://investorshub.advfn.com/uimage/uploads/2024/9/25/nwozlIMG_2141.gif
KSCP
RobotDroid RobotDroid 5 minutes ago
That's the stupidist response I will see all day....so far that is. Walgreens, that's hilarious. Soon you will be telling us McDonalds is offering Dvax with every double cheeseburger purchase.
NWBO
igorcdn igorcdn 5 minutes ago
when drill results from summer 2024 drill season comes to retail minds this going to start to move
OncoJock OncoJock 5 minutes ago
Agree. "If managed properly" is a big if.

Here's another golden oldy. It dates back to the early spring of 2022, before the phase 3 trial results were released and also before the journal article was published. I recall being very convinced and impressed by the math here, even sharing
NWBO
train21 train21 6 minutes ago
every CEO in the $OTC dilutes
its how they handle it
the more dilution the less its going to run up
BIG dilution holds back and shortens the run up spike
OTC
StockHobit StockHobit 6 minutes ago
DryWorld Industries as Nexus Energy is definitely doing business as DryWorld brands under DryWorld global under the ticker illegal burger. Try keep this straight please and thx.
IBGR
fung_derf fung_derf 6 minutes ago
You had a broker who recommended a 2 cent stock to you? Time for that guy to lose his license!
I guess if you bought in Oct '22 and sold in Feb '23, you made some nice profit. However, apparently it went up due to a pump and dump.

BTW, this may be the most vague PR I've ever
GDVM
InvestorNews1 InvestorNews1 7 minutes ago
buzz on twitter picking up. Might be a sign
PTOP
PennyMillions852 PennyMillions852 7 minutes ago
Its not crying, its FACT!!!! Coming into their own sinking the shareprice??? ok...got it....POS!!!
AHRO
dirtydozen911 dirtydozen911 8 minutes ago
this might be worth adding a little if it gets below 2 bucks
ZVSA
mzasif mzasif 8 minutes ago
You are on the wrong board - your drop from .40 to .14 is your TxRP stock, not BNCM. LOL
if you are holding 1m+ shares of BNCM, then you shouldn't go Bearish...otherwise, there is something wrong with you for holding all that and not being able to see the light at the end of the tunnel.
BNCM
big bambino big bambino 8 minutes ago
JT, as always I thank you for your input and wisdom.
ANIP
Fire_starter Fire_starter 8 minutes ago
PHARMA ARMY ABOUT TO BLOW UP THIS TICKER
RNAZ
Monroe1 Monroe1 8 minutes ago
Only 51 million shares traded!! The day is only half over.
NBRI
leverage102 leverage102 8 minutes ago
Your a Scam artist; making your own stories up Clown
NSAV
lighter than AIR lighter than AIR 8 minutes ago
lol…if they still need to pump once the audit is done, there won’t be much of an upward push.
BMXI
Itchy palm Itchy palm 8 minutes ago
I love how some Magas talk about how Taylor Swift had 17 million followers lost after backing the next President of the USA Kamala Harris. BIG deal if true she lost 5.649 % of her followers does that mean 94.351% back Kamala? I’ll take that any day of the week. 😁
tw0122 tw0122 9 minutes ago
AI is a double edged sword saves companies money but if no good paying jobs left or jobs period where you going to have the consumers to spend money on these AI companies. Huge loss of human jobs.
1 out of every 3 Americans does a gig job. Guess what ?? Uber Waymo Tesla all rolling out drive
NVDA

Your Recent History

Delayed Upgrade Clock